Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1967 1
1971 1
1972 2
1973 1
1974 2
1976 4
1977 1
1978 2
1979 3
1980 2
1981 3
1982 3
1983 2
1984 3
1985 1
1986 3
1988 1
1989 1
1990 3
1991 3
1992 2
1994 1
1995 1
1996 1
1997 2
1998 2
1999 7
2000 11
2001 7
2002 4
2003 13
2004 10
2005 13
2006 12
2007 11
2008 15
2009 10
2010 9
2011 12
2012 16
2013 37
2014 36
2015 28
2016 29
2017 37
2018 38
2019 38
2020 33
2021 41
2022 28
2023 21
2024 34
2025 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

576 results

Results by year

Filters applied: . Clear all
Page 1
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
McDonald CM, Campbell C, Torricelli RE, Finkel RS, Flanigan KM, Goemans N, Heydemann P, Kaminska A, Kirschner J, Muntoni F, Osorio AN, Schara U, Sejersen T, Shieh PB, Sweeney HL, Topaloglu H, Tulinius M, Vilchez JJ, Voit T, Wong B, Elfring G, Kroger H, Luo X, McIntosh J, Ong T, Riebling P, Souza M, Spiegel RJ, Peltz SW, Mercuri E; Clinical Evaluator Training Group; ACT DMD Study Group. McDonald CM, et al. Among authors: kaminska a. Lancet. 2017 Sep 23;390(10101):1489-1498. doi: 10.1016/S0140-6736(17)31611-2. Epub 2017 Jul 17. Lancet. 2017. PMID: 28728956 Clinical Trial.
Chloride deregulation and GABA depolarization in MTOR-related malformations of cortical development.
Bakouh N, Castaño-Martín R, Metais A, Dan EL, Balducci E, Chhuon C, Lepicka J, Barcia G, Losito E, Lourdel S, Planelles G, Muresan RC, Moca VV, Kaminska A, Bourgeois M, Chemaly N, Rguez Y, Auvin S, Huberfeld G, Varlet P, Asnafi V, Guerrera IC, Kabashi E, Nabbout R, Ciura S, Blauwblomme T. Bakouh N, et al. Among authors: kaminska a. Brain. 2025 Feb 3;148(2):549-563. doi: 10.1093/brain/awae262. Brain. 2025. PMID: 39106285 Free PMC article.
SYNGAP1-DEE: A visual sensitive epilepsy.
Lo Barco T, Kaminska A, Solazzi R, Cancés C, Barcia G, Chemaly N, Fontana E, Desguerre I, Canafoglia L, Hachon Le Camus C, Losito E, Villard L, Eisermann M, Dalla Bernardina B, Villeneuve N, Nabbout R. Lo Barco T, et al. Among authors: kaminska a. Clin Neurophysiol. 2021 Apr;132(4):841-850. doi: 10.1016/j.clinph.2021.01.014. Epub 2021 Feb 3. Clin Neurophysiol. 2021. PMID: 33639450
Neonatal seizures.
Plouin P, Kaminska A. Plouin P, et al. Among authors: kaminska a. Handb Clin Neurol. 2013;111:467-76. doi: 10.1016/B978-0-444-52891-9.00051-8. Handb Clin Neurol. 2013. PMID: 23622196
Child EEG (and maturation).
Kaminska A, Eisermann M, Plouin P. Kaminska A, et al. Handb Clin Neurol. 2019;160:125-142. doi: 10.1016/B978-0-444-64032-1.00008-4. Handb Clin Neurol. 2019. PMID: 31277843 Review.
Genetic etiologies with a large NGS panel in a monocentric cohort of 1000 patients with pediatric onset epilepsies.
Barcia G, Chemaly N, Gobin-Limballe S, Losito E, Aubart M, Sarda E, Assouline Z, Plante-Bordeneuve P, Hully M, Barrois R, Barnerias C, Sareidaki D, Zeitoun DC, Eisermann M, Fourrage C, Hanein S, Rio M, Boddaert N, Desguerre I, Kaminska A, Steffann J, Nabbout R. Barcia G, et al. Among authors: kaminska a. Epilepsia Open. 2025 May 10. doi: 10.1002/epi4.70057. Online ahead of print. Epilepsia Open. 2025. PMID: 40347095 Free article.
Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis.
Grieb P, Świątkiewicz M, Kamińska A, Jünemann A, Rejdak R, Rejdak K. Grieb P, et al. Among authors: kaminska a. Pharmaceuticals (Basel). 2021 Apr 2;14(4):326. doi: 10.3390/ph14040326. Pharmaceuticals (Basel). 2021. PMID: 33918331 Free PMC article.
Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trial.
Saxena M, Anker JF, Kodysh J, O'Donnell T, Kaminska AM, Meseck M, Hapanowicz O, Niglio SA, Salazar AM, Shah HR, Kinoshita Y, Brody R, Rubinsteyn A, Sebra RP, Bhardwaj N, Galsky MD. Saxena M, et al. Among authors: kaminska am. Nat Cancer. 2025 Jun;6(6):988-999. doi: 10.1038/s43018-025-00966-7. Epub 2025 May 9. Nat Cancer. 2025. PMID: 40346292 Clinical Trial.
576 results